While the type 2 diabetes medication, Victoza, has successfully helped those living with the disease, recent clinical trials and studies have established a potential relationship between the medication and pancreatitis, pancreatic cancer, kidney failure and thyroid cancer. Plaintiffs are currently filing lawsuits across the country to seek compensation for their injuries.
You may be entitled to file a Louisiana Victoza lawsuit if you or someone you love are taking Victoza and you have been diagnosed with a serious or life-threatening condition as a result. You may be eligible to receive compensation for pain and suffering, medical expenses including additional treatments or procedures and lost wages.
Victoza Overview
The U.S. Food and Drug Administration (FDA) initially approved Victoza, marketed and manufactured by Novo Nordisk, for use on the public market in January 2010. The drug was intended to help prevent sugar overproduction and relieve deficiencies of insulin in those living with type 2 diabetes. It quickly became a bestseller and grossed more than $670 million in 2011 alone.
However, the FDA received criticism from several of its safety reviewers before approving the medication. These individuals, responsible for researching the effectiveness and potential risks associated with different medications, asserted that Victoza could potentially cause thyroid cancer and pancreatitis.
Side Effects of Victoza
In 2011, the FDA acknowledged that there could possibly be a link between thyroid cancer and Victoza after reviewing 25 claims of the disease that were brought before the agency between February 2010 and September 2011. Those who have experienced any one or more of the following symptoms may consider filing a Louisiana Victoza lawsuit to seek compensation for their injuries:
- A lump in the neck
- Trouble breathing
- Difficulty swallowing
- Hoarseness
Additionally, you may consider filing a Louisiana Victoza lawsuit if you have been diagnosed with pancreatitis as indicated by the following symptoms:
- Upper abdominal pain
- Vomiting, nausea
- Smelly, oily stools
- Indigestion
- Weight loss
- Tenderness of abdomen
The FDA also updated Victoza’s warning label in May 2011 to reflect the potential risk of renal impairment. Plaintiffs allege that they suffered from renal impairment after suffering from vomiting, nausea, diarrhea and dehydration that often required hemodialysis. If you were diagnosed with renal impairment, consider seeking legal counsel to file a Louisiana Victoza lawsuit and obtain compensation.
Are There Current Victoza Lawsuits?
Those filing Victoza lawsuits have been involved in a pending federal multidistrict litigation (MDL) that includes other incretin mimetics such as Byetta, Januvia and Janumet. Due to the increasing number of plaintiffs expected to file lawsuits against the drugs’ manufacturers, the determination was made to consolidate cases in an effort to save time and money.
Currently, court records and an update from the Judicial Panel on Multidistrict Litigation reveal that the number of cases involving Victoza, Byetta, Januvia and Janumet has increased from 60 in September 2013 to 150 in October 2013.
Those who have taken Victoza or other incretin mimetic in an effort to help manage type 2 diabetes are urged to file a Louisiana Victoza lawsuit to seek compensation for medical bills, added hospitalizations or treatments, lost wages or expected loss of wages and pain and suffering.
Need Assistance Filing a Louisiana Victoza Lawsuit?
If you are considering filing a Louisiana Victoza lawsuit after receiving a diagnosis of cancer while taking Victoza, contact the attorneys at Attorney Group for Louisiana for more information about establishing a case. We will review your situation, determine if you are eligible to pursue a claim and connect you with professional attorneys who will see your Louisiana Victoza lawsuit throughout the legal process.
